Arrhythmias, CardiacAtrial FibrillationAtrial FlutterVentricular TachycardiaAtrial TachycardiaArrhythmogenic Right Ventricular DysplasiaLong QT SyndromeBrugada SyndromeSupraventricular TachycardiaCatecholaminergic Polymorphic Ventricular TachycardiaTorsades De PointesAtrial Cardiomyopathy
Study summary
The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia
* Age ≥ 18 years
* Written informed consent
* Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation
Exclusion Criteria:
* Insufficient knowledge of the German language to understand study documents and interview without translation
* Physical or psychological incapability to cooperate in the investigation
Primary outcome measure(s)
Time to a composite of cardiovascular mortality, stroke, acute coronary syndrome and heart failure hospitalization — Follow-up 5 years after inclusion The main primary outcome measures the time until any of death from cardiovascular cause, stroke or TIA or a hospitalization due to heart failure or acute coronary syndrome occurs for the first time after inclusion. The outcome is measured via telephone and / or in-person follow-up, acquisition of all relevant medical records between inclusion and follow-up timepoint and a questionnaire sent to the patient. The follow-up can be completed fully electronically according to patient's wish.
New onset of cardiac arrhythmias, documented in clinical care and during systematic rhythm monitoring using digital devices. — Follow-up 5 years after inclusion The outcome is measured via remote follow-up using consumer-electronics based remote rhythm monitoring technologies. Additionally, onset of new cardiac arrhythmias is assessed from medical records collected between follow-up timepoint and inclusion as well as questionnaires and a telephone call with the patient.
Trial sites (1)
Facility
City
Region
Status
University Hospital Hamburg-Eppendorf, University Heart and Vascular Center
Hamburg
Germany
Recruiting
More Universitätsklinikum Hamburg-Eppendorf trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.